1,2-Dichloroethane → HCID 23657984, compound
Reaction equation
[CH3:1][N:2]1[C:10]2[CH:9]=[C:8]([CH:11]3[CH2:16][CH2:15][NH:14][CH2:13][CH2:12]3)[C:7](=[O:17])[NH:6][C:5]=2[CH:4]=[CH:3]1.[Cl:18][C:19]1[C:27]2[NH:26]N=[CH:24][C:23]=2[C:22]2[CH2:28][N:29]([CH2:38][C:39]([CH3:42])([CH3:41])[CH3:40])[C:30](=[O:37])[C@H:31]([CH2:33][C:34]([OH:36])=O)[CH2:32][C:21]=2[CH:20]=1.[CH:43]1C=CC2N(O)N=NC=2C=1.C(Cl)CCl.C(N(C(C)C)CC)(C)C>CN(C=O)C>[Cl:18][C:19]1[CH:20]=[C:21]2[CH2:32][C@@H:31]([CH2:33][C:34]([N:14]3[CH2:15][CH2:16][CH:11]([C:8]4[C:7](=[O:17])[NH:6][C:5]5[CH:4]=[CH:3][N:2]([CH3:1])[C:10]=5[CH:9]=4)[CH2:12][CH2:13]3)=[O:36])[C:30](=[O:37])[N:29]([CH2:38][C:39]([CH3:42])([CH3:40])[CH3:41])[CH2:28][C:22]2=[C:23]2[C:27]=1[NH:26][CH:43]=[CH:24]2Participants
Procedure
To a mixture of 1-methyl-6-(piperidin-4-yl)-1H-pyrrolo[3,2-b]pyridin-5(4H)-one (41 mg, 0.177 mmol), (S)-2-(4-chloro-9-neopentyl-8-oxo-3,6,7,8,9,10-hexahydroazepino[3,4-e]indazol-7-yl)acetic acid (64.5 mg, 0.177 mmol), HOBT (26.3 mg, 0.195 mmol) and EDC (37.4 mg, 0.195 mmol) in DMF (2 mL) was added diisopropylethylamine (108 μl, 0.620 mmol) at rt. The resulting mixture was stirred at rt over night, most of the solvent was removed under N2, the residue was purified on reverse phase PrepHPLC to afford a grey gum which was triturated with Et2O (2 mL), filtered and washed with Et2O (2×0.5 mL) to afford the expected product, (S)-7-chloro-4-(2-(4-(1-methyl-5-oxo-4,5-dihydro-1H-pyrrolo [3,2-b]pyridin-6-yl)piperidin-1-yl)-2-oxoethyl)-2-neopentyl-1,2,4,5-tetrahydroazepino[3,4-e]indol-3(8H)-one (32 mg grey solid. Mass spec: 577.30 (MH+) calc. for C31H37ClN6O3 576.26.
Workup
- customwas removed under N2
- customthe residue was purified on reverse phase PrepHPLC
- customto afford a grey gum which
- customwas triturated with Et2O (2 mL)
- filtrationfiltered
- washwashed with Et2O (2×0.5 mL)
Sources & evidence
- ORD record
- ord-990c8adcb9344c39bfdcbc1cb30ea1b9
- Source dataset
- uspto-grants-2008_12
- Patent number
- US07470680B2
Reaction notes
Loading…